Related by context. All words. (Click for frequent words.) 86 colon cancer 81 ovarian cancer 81 prostate cancer 78 breast cancer 77 colorectal cancers 77 lung cancer 75 cancers 74 breast cancers 74 gastric cancer 74 rectal cancer 74 melanoma 73 colorectal cancer CRC 73 endometrial cancer 73 bladder cancer 73 prostate cancers 72 ovarian cancers 72 invasive breast cancer 72 bowel cancer 71 cancer 71 cardiovascular disease 70 pancreatic cancer 70 liver cancer 70 colorectal 69 breast cancer recurrence 69 cervical cancer 69 metastatic breast cancer 68 colon cancers 68 metastatic prostate cancer 67 HER2 positive breast cancer 67 heart disease 67 rectal cancers 67 esophageal cancer 67 lung cancers 67 prostrate cancer 66 colorectal cancer screening 66 endometrial cancers 66 NSCLC 66 bladder cancers 66 malignancy 65 Colorectal cancer 65 malignant melanoma 65 multiple myeloma 65 colorectal adenomas 65 malignancies 65 bowel cancers 64 pancreatic cancers 64 metastatic disease 64 renal cell carcinoma 64 breast tumors 64 oesophageal cancer 64 HNSCC 64 Prostate cancer 64 oropharyngeal cancer 63 metastatic cancer 63 gynecologic cancer 63 BRCA mutations 63 Colon Cancer 63 adenocarcinoma 63 metastatic colorectal cancer 63 Breast cancer 63 gynecologic cancers 63 pre cancerous polyps 63 gynecological cancers 63 metastatic colon cancer 63 postmenopausal breast cancer 63 colo rectal cancer 62 NAFLD 62 colorectal tumors 62 colorectal neoplasia 62 lymphoma 62 CaP 62 Colorectal Cancer 62 lung tumors 62 invasive cervical cancer 62 pancreatic adenocarcinoma 62 lobular breast cancer 62 gastrointestinal cancers 61 colorectal polyps 61 esophageal adenocarcinoma 61 adenomas 61 pleural mesothelioma 61 Lung cancer 61 esophageal cancers 61 melanomas 61 nonmelanoma skin cancer 61 prostate specific 61 prostate cancer CaP 61 tumor recurrence 61 Barrett esophagus 61 malignant pleural mesothelioma 61 colon rectal cancer 61 hepatocellular carcinoma 61 coronary artery disease 61 coronary disease 61 tumors 61 colon tumors 61 Prostate Cancer 61 nonsmall cell lung cancer 61 ductal cancer 61 HER2 positive 60 adenoma 60 localized prostate cancer 60 medullary thyroid cancer 60 distant metastases 60 colon polyps 60 cutaneous melanoma 60 laryngeal cancer 60 uterine cancers 60 polyp recurrence 60 prostate tumors 59 hereditary breast cancer 59 gastric cancers 59 nonmelanoma skin cancers 59 Ovarian cancer 59 colorectal screening 59 cell lung cancer 59 neoplasia 59 squamous cell carcinoma 59 lobular cancer 59 carcinoma 59 precancerous lesions 59 pre cancerous lesions 59 testicular cancers 59 PCa 59 Gastric cancer 59 CMV disease 59 adenomatous polyps 59 advanced adenoma 59 skin cancers 59 Hepatocellular Carcinoma HCC 59 Stomach cancer 59 colorectal adenoma 59 disease 59 PSA velocity 59 COPD 59 epithelial ovarian cancer 58 breast endometrial 58 curable cancers 58 antigen PSA 58 peritoneal cancer 58 diffuse gastric 58 prostate cancer PCa 58 malignant tumors 58 diabetes 58 HPV infection 58 prostate cancer CRPC 58 cardiovascular disease CVD 58 thyroid cancer 58 lobular carcinoma 58 squamous cell cancer 58 benign breast 58 advanced adenomas 58 seminoma 58 Bowel cancer 58 acute myelogenous leukemia AML 58 prostate adenocarcinoma 58 disease progression 58 glioblastoma 58 squamous cell cancers 58 osteoporosis 58 endometrial hyperplasia 58 recurrent ovarian cancer 58 lung colorectal 58 non Hodgkin lymphoma 58 colon cancer screening 58 BRCA2 mutations 58 Lung Cancer 58 metastatic lung cancer 58 adjuvant therapy 58 hepatocellular carcinoma HCC 57 kidney disease 57 colorectal breast 57 H. pylori infection 57 squamous cell carcinomas 57 advanced NSCLC 57 HPV 57 breast carcinoma 57 distant metastasis 57 venous blood clots 57 Non Hodgkin lymphoma 57 brain tumors 57 metastatic 57 Pancreatic Cancer 57 squamous cell 57 gallstone disease 57 gum disease 57 Rectal cancer 57 metabolic syndrome 57 liver metastases 57 metastases 57 carcinoid cancer 57 chlamydial infection 57 HCV infection 57 coronary heart 57 Melanoma 57 cervical cancers 57 periodontitis 57 familial pancreatic cancer 57 hepatocellular cancer 57 carcinoid tumors 57 cardiovascular mortality 57 prostate tumor 57 colorectal lung 57 pre cancerous growths 57 VTE 56 PSADT 56 PSA screening 56 LQTS 56 differentiated thyroid 56 Testicular cancer 56 prostate specific antigen 56 EGFR mutation 56 lymphomas 56 Alzheimer disease 56 Cholangiocarcinoma 56 cervical lesions 56 Bladder cancer 56 vascular disease 56 metastatic melanoma 56 colon breast 56 precursor lesions 56 serous ovarian cancer 56 lung adenocarcinoma 56 uveal melanoma 56 hormone receptor positive 56 pharyngeal cancer 56 cervical carcinoma 56 microalbuminuria 56 chronic kidney 56 tamoxifen 56 prediabetes 56 basal cell carcinomas 56 premenopausal breast cancer 56 metastatic renal cell carcinoma 56 postmenopausal women 56 breast ovarian 56 soft tissue sarcomas 56 neuroendocrine tumors 56 BRCA mutation 56 ductal breast cancer 56 ovarian tumors 56 BRCA1 mutations 56 testicular cancer 56 fecal occult blood 56 gestational diabetes 56 intestinal polyps 56 recurrent prostate cancer 56 colorectal cancer incidence 56 cancerdefine 56 atypical ductal hyperplasia 56 oesophageal adenocarcinoma 56 DCIS 56 ALCL 56 thyroid cancers 56 Cancer 56 precancerous polyps 56 KRAS mutation 56 atypical hyperplasia 56 basal cell carcinoma BCC 56 venous thromboembolism 56 squamous cell lung cancer 55 metastatic gastric 55 breast cervical 55 colorectal bowel 55 Helicobacter pylori infection 55 grade gliomas 55 Barrett Esophagus 55 BRCA mutation carriers 55 Prostate Specific Antigen PSA 55 gynecological cancer 55 basal cell carcinoma 55 breast prostate 55 Ovarian Cancer 55 adjuvant chemotherapy 55 hip fracture 55 MGUS 55 atherosclerosis 55 thromboembolic disease 55 nasopharyngeal carcinoma 55 liver disease 55 uterine cancer 55 preeclampsia 55 ovarian breast 55 liver fibrosis 55 Cervical cancer 55 bladder tumors 55 testicular germ cell 55 ovarian lung 55 bone metastasis 55 urinary bladder cancer 55 lymph node metastases 55 atherosclerotic disease 55 prostate lung 55 operable breast cancer 55 prostate cancer mCRPC 55 metastatic colorectal 55 severe sepsis 55 axillary dissection 55 follicular lymphoma 55 basal cell nevus syndrome 55 adjuvant radiation 55 chronic lymphocytic leukemia CLL 55 sarcoma 55 leukemia ALL 55 contralateral breast cancer 55 CLL 55 estrogen receptor negative 55 hip fractures 55 Pancreatic cancer 55 angiosarcoma 55 atrial fibrillation 55 distal colon cancer 55 hormone refractory prostate cancer 55 chlamydia infection 55 malignant lymphoma 55 relapsed ovarian cancer 55 BRCA2 gene mutation 55 metastatic cancers 55 node metastases 55 colorectal carcinoma 54 periodontal disease 54 alcoholic cirrhosis 54 osteoporotic fractures 54 situ LCIS 54 clinically localized prostate 54 CMV infection 54 melanoma skin 54 cholangiocarcinoma 54 erlotinib 54 selenium supplementation 54 GISTs 54 ovarian pancreatic 54 dysglycemia 54 vandetanib 54 lupus 54 chronic lymphocytic leukemia 54 serum PSA 54 statin therapy 54 precancerous cervical lesions 54 Oesophageal cancer 54 colorectal neoplasms 54 prostate pancreatic 54 non squamous NSCLC 54 uterine ovarian 54 intensive statin therapy 54 Hodgkin lymphoma HL 54 recurrent colorectal cancer 54 adenoid cystic carcinoma 54 brain metastases 54 metastatic bladder 54 advanced neoplasia 54 oophorectomy 54 HBV infection 54 recurrent VTE 54 neovascular AMD 54 adenocarcinomas 54 cardio vascular disease 54 gynecologic malignancy 54 renal carcinoma 54 Adjuvant chemotherapy 54 preterm birth 54 pre menopausal 54 recurrent metastatic 54 precancer 54 mammography screening 54 biliary cancer 54 metastatic HER2 positive 54 invasive carcinoma 54 statins 54 preterm delivery 54 Colorectal 54 GIST 54 PCNSL 54 cardiovascular diseases 54 renal cell carcinomas 54 inflammatory bowel disease 54 atypia 54 HER2 overexpression 54 childhood leukemia 54 cell carcinoma 54 precancerous colon polyps 54 ischemic stroke 54 Multiple Myeloma 54 colon rectal 54 tumor 54 axillary lymph nodes 54 systemic scleroderma 54 breast colorectal 54 bowel polyps 54 myeloma 54 HRPC 54 cetuximab Erbitux 54 breast colon 54 hypertension 53 yearly mammograms 53 proliferative diabetic retinopathy 53 mRCC 53 breast carcinomas 53 papillary thyroid cancer 53 ulcerative colitis 53 pancreatic NET 53 chemoradiotherapy 53 subclinical hyperthyroidism 53 ovarian 53 Colorectal cancer screening 53 neuroblastoma 53 castration resistant prostate cancer 53 Renal Cell Carcinoma RCC 53 alpha carotene 53 micrometastases 53 acute myeloid leukemia 53 myelodysplastic syndrome MDS 53 latent TB infection 53 endometrial kidney 53 Waldenstrom macroglobulinemia 53 vertebral fracture 53 vitamin D intake 53 squamous cell skin 53 screening mammography 53 Crohn disease 53 neoplasia PIN 53 BRCA1 53 endometrial tumors 53 thyroid nodules 53 CT colonography 53 chemoprevention 53 Colorectal cancer CRC 53 leukemia AML 53 hormonal therapy 53 ovulatory infertility 53 bone metastases 53 ADPKD 53 gastrointestinal stromal tumors 53 gastric adenocarcinoma 53 prostate carcinoma 53 neoplasias 53 premalignant lesions 53 modifiable risk 53 precancerous growths 53 screening colonoscopies 53 soft tissue sarcoma 53 Alzheimer disease AD 53 severe psoriasis 53 sunitinib 53 cervical uterine 53 metastatic pancreatic cancer 53 spontaneous preterm delivery 53 Wilms tumor 53 elevated CRP 53 H. pylori 53 cervical breast 53 de ath 53 fibroadenomas 53 celiac disease 53 AAT deficiency 53 HIV infection 53 Non Hodgkin Lymphoma 53 esophageal squamous cell carcinoma 53 diabetic nephropathy 53 HNPCC 53 EUS FNA 53 Cristofanilli 53 Lymphoma 53 recurrent stroke 53 situ DCIS 53 folic acid intake 53 pancreatic lung 53 bile duct cancers 53 osteoporotic fracture 53 nonalcoholic steatohepatitis NASH 53 leukaemias 53 prostate 53 gastrointestinal stromal tumor GIST 53 asymptomatic 53 EGFR mutations 53 Bladder Cancer 53 HER2 positive metastatic breast 53 CIN3 + 53 premenopausal 53 metastatic kidney 53 benign proliferative breast 53 cervical cancer screening 53 Thyroid cancer 53 malignant growths 53 basal cell cancer 53 Carcinoma 53 grade glioma 53 atherothrombotic events 53 solid tumors 53 Malignant Melanoma 53 pelvic malignancies 53 vitamin D deficiency 53 lymphoma CTCL 53 gefitinib 53 specific antigen 53 dasatinib 53 disease NAFLD 53 mesotheliomas 53 Flexi Scope 53 invasive lobular 53 APOL1 53 diabetic retinopathy 53 scleroderma 53 sudden cardiac death 53 dietary acrylamide 53 ccRCC 53 ovarian carcinoma 53 colon esophageal 52 idiopathic pulmonary fibrosis IPF 52 adjuvant radiotherapy 52 BRCA2 mutation 52 intravenous bisphosphonates 52 DVT PE 52 cutaneous squamous cell carcinoma 52 chronic periodontitis 52 breast cancer recurrences 52 epithelial tumors 52 venous thrombosis 52 cardiotoxicity 52 hormone therapy 52 medically inoperable 52 diagnose Alzheimer disease 52 grade cervical intraepithelial 52 metastatic RCC 52 sorafenib 52 metastatic malignant melanoma 52 lipid abnormalities 52 folate deficiency 52 IV melanoma 52 Velcade bortezomib 52 CVD 52 vitamin D 52 recurrent NSCLC 52 Oral Cancer 52 metastasis 52 retinoblastoma 52 olaparib 52 gastrointestinal GI cancers 52 acute myeloid leukemia AML 52 diabetes mellitus 52 genetic variations 52 neoadjuvant therapy 52 fallopian tube carcinoma 52 GIST tumors 52 NSABP 52 colorectal polyp 52 peripheral artery disease 52 bile duct cancer 52 malignant mesothelioma 52 urothelial carcinoma 52 SCCHN 52 hormonal therapies 52 breast caner 52 adenoma recurrence 52 neoadjuvant treatment 52 biochemical recurrence 52 Glioblastoma Multiforme 52 familial ALS 52 postoperative delirium 52 hydroxyvitamin D levels 52 ependymoma 52 screening colonoscopy 52 MetS 52 dementia 52 Esophageal cancer 52 Acute myeloid leukemia 52 asymptomatic carotid stenosis 52 nonmetastatic 52 osteosarcoma 52 gastrointestinal stromal tumor 52 ductal adenocarcinoma 52 Pap smear 52 deCODE BreastCancer TM 52 CIN3 52 papillary renal cell carcinoma 52 anal cancer 52 liver metastasis 52 invasive pneumococcal disease 52 Alzheimers disease 52 Adenomas 52 cisplatin chemotherapy 52 metachronous 52 colorectal liver metastases 52 anal cancers 52 familial adenomatous polyposis 52 HCV infections 52 psoriasis 52 peripheral arterial disease 52 pre cancerous cells 52 HER2 + 52 cardiovascular disease hypertension 52 pancreatic tumor 52 breast cancer Narod 52 Uterine cancer 52 gliomas 52 Prostate Cancer ERSPC 52 cerebral infarction 52 GnRH agonists 52 cetuximab 52 statin 52 S. aureus infections 52 Colorectal cancers 52 gene variants 52 mutated KRAS gene 52 invasive ductal 52 Digital Mammographic Imaging 52 FSGS 52 AA Amyloidosis 52 abnormal Pap tests 52 malignant polyps 52 gefitinib Iressa 52 estrogen progestin therapy 52 BRAF mutation 52 malignant melanomas 52 T2D 52 IV metastatic melanoma 52 abiraterone 52 tumor progression 52 prostate colon 52 Esophageal Cancer 52 prolongs survival 52 BRCA2 mutation carriers 52 Testicular Cancer 52 prostate ovarian 52 neoadjuvant chemotherapy 52 pancreatic tumors 52 pre eclampsia 52 hyperphosphatemia 52 bevacizumab Avastin 52 onset Alzheimer disease 52 breast uterine 52 cabazitaxel 52 prostate carcinogenesis 52 iron overload 52 folate intake 52 cirrhosis 52 mCRC 52 endometrial 52 subclinical hypothyroidism 52 poorer prognosis 52 postoperative pulmonary 52 secondary hyperparathyroidism 52 Radical prostatectomy 52 myeloid leukemia 52 HER2 positive cancers 52 systemic lupus erythematosus SLE 52 precancerous 52 selenium intake 52 androgen deprivation 52 osteosarcomas 52 chronic prostatitis 52 squamous cell carcinoma SCC 52 chemoradiation 52 ASCUS 52 myocardial infarction MI 52 digestive tract cancers 52 abnormal mammograms 52 peritoneal carcinomatosis 52 medulloblastoma 52 breast cancer metastasis 51 pancreatic neuroendocrine tumors 51 indolent NHL 51 Breast Cancer 51 CIN2 + 51 MYH9 gene 51 anastrozole 51 thromboembolic events 51 premalignant 51 tamoxifen therapy 51 IV malignant melanoma 51 acute coronary syndrome 51 gout 51 postoperative atrial fibrillation 51 elevated triglyceride levels 51 endometrial carcinoma 51 precancerous polyp 51 heavily pretreated 51 diverticulosis 51 exfoliation glaucoma 51 Seewaldt 51 Sentinel node biopsy 51 polyps 51 prostate breast 51 Endometrial cancer 51 BRCA genes 51 overexpress HER2 51 precancers 51 undergone radical prostatectomy 51 CHD 51 post menopausal 51 inoperable pancreatic cancer 51 gemcitabine chemotherapy 51 pre cancerous 51 colonic polyps 51 chronic diseases 51 Androgen deprivation therapy 51 thromboembolism 51 abnormal mammogram 51 cancerous polyps 51 benign polyps 51 glioma rarer 51 rectal carcinoma 51 undergoing radical prostatectomy 51 recurrent myocardial infarction 51 lupus nephritis 51 Hodgkin lymphoma 51 Glioblastoma Multiforme GBM 51 ErbB2 positive 51 carotid stenosis 51 superficial bladder cancer 51 Non Hodgkins lymphoma 51 mammographic density 51 AA amyloidosis 51 glioblastomas 51 gastric carcinoma 51 colon cancer screenings 51 diverticular bleeding 51 Burkitt lymphoma 51 BRCA deficient 51 SIR Spheres microspheres 51 diagnosing Alzheimer disease 51 pCR 51 minimally symptomatic 51 lipid lowering therapy 51 pelvic lymphadenectomy 51 beta carotene supplementation 51 CHD mortality 51 postoperative mortality 51 prostate cancer AIPC 51 IV NSCLC 51 PSA prostate 51 testosterone supplementation 51 cystatin C 51 mammograms 51 Menopausal hormone therapy 51 Prostate specific antigen 51 ovarian cervical 51 IV bisphosphonates 51 nonalcoholic steatohepatitis 51 fragility fractures 51 ductal carcinoma 51 spontaneous preterm birth 51 SLNB 51 Prostate Cancer Prevention 51 CYP#C# [001] 51 specific antigen PSA 51 Cancer Institute 51 potentially cancerous polyps 51 lignan intake 51 oesophageal cancers 51 advanced hepatocellular carcinoma 51 metastatic NSCLC 51 latent TB 51 rs# [002] 51 metastatic tumors 51 cervical dysplasia 51 atopic disease 51 Alzheimer 51 hemodialysis patients 51 renal tumors 51 breast pancreatic 51 epithelial ovarian 51 Torisel 51 colon adenomas 51 anaplastic 51 Tavocept 51 Paget disease 51 chronic HBV infection 51 Pap smear screening 51 liver transplantation 51 Chlamydia infection 51 human papillomavirus HPV 51 PCA3 scores 51 genital herpes infections 51 carcinomas 51 tumor histology 51 colon polyp 51 LRP5 51 Metastatic breast cancer 51 cardiovascular morbidity 51 curative resection 51 #.#ng/ml 51 prostate cancer HRPC 51 CC genotype 51 sigmoidoscopy 51 trastuzumab 51 Chronic Kidney Disease 51 postmenopausal hormone 51 metastatic GIST 51 relapsing remitting MS 51 thrombotic events 51 cervical intraepithelial neoplasia 51 DLBCL 51 HGPIN 51 Screening Trial DMIST 51 acid secretion 51 HER2 51 leukemia 51 HIV HCV coinfected 51 testicular tumors 51 irinotecan chemotherapy 51 unresectable 51 precancerous cervical 51 cruciferous vegetables 51 metastatic ovarian cancer 51 basal cell 51 subclinical atherosclerosis 51 locoregional 51 rheumatoid arthritis RA 51 coronary artery calcium 51 smoldering myeloma 50 myocardial infarction 50 cirrhosis liver failure 50 Renal cell carcinoma 50 SEER database 50 Invasive Breast Cancer 50 Glioblastoma 50 TGFBR1 * 6A 50 adjuvant therapies 50 H. pylori eradication 50 systemic lupus erythematosus 50 Mantle Cell Lymphoma 50 acute GVHD 50 folate supplementation 50 T1DM 50 Basal cell 50 cirrhotic patients 50 hepatitis C infection 50 mammary tumors 50 screening mammograms 50 hereditary predisposition 50 stage IIIB 50 potentially cancerous growths 50 HbA1C 50 inflammatory arthritis 50 Septin9 50 hormone deprivation 50 2 diabetes T2D 50 relapsed SCLC 50 beta carotene supplements 50 colorectal screenings 50 Prostate Specific Antigen 50 Vectibix 50 histological subtype 50 detecting colorectal cancer 50 WNV infection 50 gastrointestinal stromal tumors GIST 50 invasive candidiasis 50 prostate colorectal 50 BRCA carriers 50 unresectable liver cancer 50 basal cell cancers 50 folate 50 type 1diabetes 50 KRAS status 50 HBeAg negative 50 Adenocarcinoma 50 pediatric malignancies 50 synovial sarcoma 50 lung colon 50 BRCA2 50 preoperative chemotherapy 50 GBM tumors 50 urothelial bladder cancer 50 HPV infections 50 PROLARIS 50 Fatty Liver Disease 50 axitinib 50 dietary folate intake 50 ELCAP 50 lung adenocarcinomas 50 panitumumab Vectibix 50 osteoporotic 50 estrogen receptor positive 50 colorectal prostate 50 carotid plaque 50 medulloblastomas 50 stage IIIB IV 50 multiple myeloma MM 50 sCJD 50 colorectal cancer screenings 50 knee osteoarthritis 50 cancer mCRC 50 Lung transplantation 50 Thyroid nodules 50 prophylactic mastectomy 50 kidney dysfunction 50 carcinoid 50 frequently benign tumor 50 KRAS wild 50 symptomatic fibroids 50 imatinib Gleevec 50 ductal carcinomas 50 familial adenomatous polyposis FAP 50 TORISEL 50 Erbitux cetuximab 50 acute leukemias 50 renal dysfunction 50 urolithiasis 50 telomere lengths 50 metastatic pancreatic 50 SHPT 50 contralateral breast 50 oropharyngeal squamous cell carcinoma 50 5-FU/LV 50 dutasteride 50 cancerous breast 50 Alessandro Riva 50 PAOD 50 Burkitt Lymphoma 50 Alzheimer Disease AD 50 Colon polyps 50 coronary calcification 50 Squamous cell 50 mammography 50 HSCT 50 squamous 50 CDH1 50 urothelial cancer 50 antitumor effect 50 hormone therapy estrogen 50 prophylactic mastectomies 50 skeletal metastases 50 resistant ovarian cancer 50 carcinoid tumor 50 BRCA 50 test FOBT 50 HBV 50 basal cell skin 50 severe oral mucositis 50 NHANES III 50 C. difficile infections 50 onset Alzheimer 50 CKD 50 polycythemia vera 50 R0 resection 50 pancreatic carcinoma 50 leiomyomas 50 postmenopausal 50 metformin 50 KRAS mutations 50 diabetes mellitus DM 50 macular degeneration 50 glioma 50 atherothrombotic disease 50 mammographies 50 HPV# 50 endometriosis 50 thrombophilia 50 asymptomatic PAD 50 non Hodgkin lymphomas 50 Li Fraumeni 50 cancerous lesions 50 tumor subtypes 50 Squamous 50 antiplatelet therapy 50 Metastatic melanoma 50 Epithelial ovarian cancer 50 axillary node dissection 50 Prostate Lung Colorectal 50 cisplatin resistant 50 lymphadenectomy 50 Metastatic 50 mycophenolate mofetil 50 urate levels 50 refractory multiple myeloma 50 BRCA1 mutation carriers 50 grade dysplasia 50 unresectable tumors 50 upper gastrointestinal bleeding 50 anthracyclines 50 Halaven 50 FGFR2 50 hepatitis B infection 50 perioperative morbidity 50 colonoscopy sigmoidoscopy 50 non hodgkin lymphoma 50 Dr Zorbas 50 malignant brain 50 lymph node involvement 50 vegetable intake 50 Heart Disease 50 Xeloda 50 Breast Cancer Risk 50 hematologic malignancies 50 GSTP1 50 relapsing remitting MS RRMS 50 mCRC patients 50 unresectable stage 50 Cancers 50 breast conserving 50 antihypertensive therapy 50 familial hypercholesterolemia 50 non Hodgkin Lymphoma 50 Folotyn 50 chemopreventive agent 50 postoperative AF 50 palliative radiotherapy 50 advanced epithelial ovarian